Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...
A new surgical technique known as NeuroSAFE is offering new hope to men undergoing prostate cancer surgery, nearly doubling the chances of preserving erectile function without compromising cancer ...
The 61-year-old Melbourne dad, who has a family history of prostate cancer, was diagnosed with the disease in late 2020. He chose to have a radical robotic prostatectomy, of which erectile dysfunction ...
The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in TheLancet Oncology, raise the prospect of major quality of ...
Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...
Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results